Sinusitis: Clinical Trials

4 trials for Sinusitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4

Follow Sinusitis: new trials by email Literature Review of Sinusitis trials Research Report on Sinusitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)
Dupilumab, Placebo, Intranasal Corticosteroid Sprays (INCS) - Allergic Fungal Rhinosinusitis
Phase 3TerminatedEmory University52023-10-262025-05-08
Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients
Tobramycin nebulized nasally, Physiologic serum nebulized nasally - Cystic Fibrosis, Rhinosinusitis
Phase 3TerminatedVirginie ESCABASSE862017-02-162023-02-15
Rates of Middle Meatus Synechiae Formation Post Endoscopic Sinus Surgery
Restora™ Steroid eluting spacer, Silastic Silicone Spacer - Sinusitis
Phase 3TerminatedCedars-Sinai Medical Center32015-12-012017-11-17
The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)
MFNS and antibiotic, Matching Placebo nasal spray plus antibiotic - Sinusitis
Phase 3TerminatedOrganon and Co2372006-12-012024-05-20

Narrower conditions

Allergic Fungal Sinusitis (1)  ·  Cystic Fibrosis (1)  ·  Lung Diseases (1)  ·  Rhinosinusitis (1)

Broader conditions

Infections (4)  ·  Nose Diseases (4)  ·  Otorhinolaryngologic Diseases (4)  ·  Paranasal Sinus Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Infections (4)  ·  Bacterial Infections and Mycoses (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Infant, Newborn, Diseases (1)

Interventions

Anti-Bacterial Agents (1)  ·  Sodium Chloride (1)  ·  Tobramycin (1)  ·  dupilumab (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Emory University (1)  ·  Organon and Co (1)  ·  Virginie ESCABASSE (1)

Countries

United States (2)  ·  France (1)

Top investigators

Joshua M Levy, MD, MPH, MSc (1)  ·  Martin L Hopp, MD (1)  ·  Virginie Escabasse, MD (1)

Results publications

PMID 35390177